Literature DB >> 2988832

Immune functions in homosexual men with antibodies to HTLV-III in Finland.

K Krohn, A Ranki, J Antonen, S L Valle, J Suni, A Vaheri, C Saxinger, R C Gallo.   

Abstract

The occurrence of HTLV-III antibodies in a voluntary group of 175 homosexual men in a low risk AIDS area was studied, and the findings were correlated to clinical, virological, immunological and lifestyle parameters. Fifteen of 175 men had HTLV-III antibodies; two of these had AIDS, five had LAS and two had enlarged lymph nodes. In the HTLV-III antibody negative group, no signs of AIDS or pre-AIDS were seen during a 10 month follow-up. In HTLV-III antibody positive individuals, low TH/TS ratio was mainly due to decreased number of TH cells. Most HTLV-III antibody positive cases had low responses to a specific antigen, PPD, while responses to the mitogens PHA and PWM were only slightly affected. In HTLV-III antibody negative cases, 13% had a low TH/TS ratio, mostly due to elevation of TS cells. In this group, mitogen and antigen responses were normal or only slightly affected. The results reinforce the causal relationship between HTLV-III and AIDS and suggest that the cells primarily affected by the virus infection are TH cells, responsible for antigen specific responses. Longitudinal studies are required to find out, what is the relationship of immune response to the development of clinical AIDS in HTLV-III infected individuals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988832      PMCID: PMC1577013     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Relation between sexual practices and T-cell subsets in homosexually active men.

Authors:  R Detels; J L Fahey; K Schwartz; R S Greene; B R Visscher; M S Gottlieb
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

2.  T-lymphocyte subpopulations in homosexual men.

Authors:  H Kornfeld; R A Vande Stouwe; M Lange; M M Reddy; M H Grieco
Journal:  N Engl J Med       Date:  1982-09-16       Impact factor: 91.245

Review 3.  The acquired immune deficiency syndrome.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

4.  Immunological characterization of homosexual males.

Authors:  J M Reuben; E M Hersh; P W Mansell; G Newell; A Rios; R Rossen; A L Goldstein; J E McClure
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

5.  Persistent, generalized lymphadenopathy among homosexual males.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-05-21       Impact factor: 17.586

6.  Update on acquired immune deficiency syndrome (AIDS)--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1982-09-24       Impact factor: 17.586

7.  Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.

Authors:  A Uotila; K M Marnela; A Hamblin; K Krohn
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings.

Authors:  M C Poon; A Landay; E F Prasthofer; S Stagno
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

9.  Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

Authors:  W L Farrar; H M Johnson; J J Farrar
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

10.  Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis.

Authors:  J Sonnabend; S S Witkin; D T Purtilo
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

View more
  8 in total

1.  Efficacy of intravenous immunoglobulins in patients with advanced HIV-1 infection. A randomized clinical study.

Authors:  U Brunkhorst; M Stürner; H Willers; H Deicher; I Schedel
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

Review 2.  The natural history of human T lymphotropic virus-III infection: the cause of AIDS.

Authors:  M Melbye
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

3.  Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.

Authors:  K Krohn; W G Robey; S Putney; L Arthur; P Nara; P Fischinger; R C Gallo; F Wong-Staal; A Ranki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

5.  HIV through the looking glass: insights derived from Hepatitis B.

Authors:  Maria M Rivera; Alejandro Soza; Alison Jazwinski; Lijun Mi; David E Kleiner; Xiongce Zhao; Charma Zuber; Douglas Brust; Emory Hsu; Jennifer Simpson; Jay H Hoofnagle; Theo Heller
Journal:  J Acquir Immune Defic Syndr       Date:  2015-02-01       Impact factor: 3.731

6.  Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.

Authors:  A Ranki; S H Weiss; S L Valle; J Antonen; K J Krohn
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

7.  Prostaglandin E2 administered via anus causes immunosuppression in male but not female rats: a possible pathogenesis of acquired immune deficiency syndrome in homosexual males.

Authors:  S Kuno; R Ueno; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.

Authors:  J Antonen; K Krohn
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.